In Brief: Oats/CHD
This article was originally published in The Tan Sheet
Executive Summary
Oats/CHD: FDA announces its authorization of the use of food label health claims associating consumption of whole oats, including oat bran, rolled oats and whole oat flour, with reduced coronary heart disease in a Jan. 23 Federal Register notice. The authorization marks the first time that a food substance has been permitted to make a health claim. The agency states that beta-glucan soluble fiber, the type found in whole oats, is primarily responsible for the "observed lowering of blood cholesterol levels." An acceptable claim offered by the agency states: "Beta-glucan soluble fiber from whole oats, as part of a diet low in saturated fat and cholesterol, may reduce the risk of coronary heart disease"...
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning